No additional weight-loss reported from a lifestyle programme for people with psychosis
People with schizophrenia are twice as likely to be overweight as the general population, as medication side effects frequently include weight gain. This NIHR-funded study with over 400 participants in 10 areas across England is the largest UK randomised trial to date.
It shows that this hard-to-reach group can be recruited and retained in structured self-management programmes delivered by trained facilitators. However, it was neither clinically effective nor cost-effective.
Alternative, affordable approaches are much needed.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
More News: Health | National Institute for Health Research (NIHR) | Obesity | Schizophrenia | Study | Weight Loss